Treatment of Breast Cancer with Natural Products

Erscheinungsjahr 2024
ISBN: 978-0-443-29913-1
Verlag: Elsevier Science & Technology

Buch, Englisch, Format (B × H): 152 mm x 229 mm, Gewicht: 450 g

Treatment of Breast Cancer with Natural Based Products is designed to provide a wide spectrum of information and knowledge on phytotherapeutics in breast cancer treatment. With a strong focus on the established research and technology on phytoconstituent-based nanocarriers, the book also covers their rapidly emerging aspects and discusses future research directions in the treatment of breast cancer. Users will find insights into breast cancer symptoms, epidemiology, risk factors, screening, treatment, and drugs delivery systems. Other sections cover Curcumin, Paclitaxel, Quercetin, Resveratrol, Sulforaphane, Epigallocatechin-3-Gallate, Allicin, Berberine, and Vinca Alkaloids in the treatment of breast cancer, along with future perspectives.

This book presents a groundbreaking opportunity for both academia and industry to reshape contemporary medical and healthcare approaches. With a specific emphasis on various facets of phytoconstituents within the realm of oncology, this publication serves as a precious asset for researchers, as well as graduate and post-graduate students specializing in oncology, pharmaceutical sciences, biotechnology, and related biomedical fields.

Autoren/Hrsg.

Mishra, Yachana

Mishra, Vijay

Fachgebiete

• Naturwissenschaften Biowissenschaften Biowissenschaften

Inhaltsverzeichnis

1. Breast cancer: An insight
2. Curcumin in breast cancer treatment
3. Paclitaxel in breast cancer treatment
4. Quercetin in breast cancer treatment
5. Resveratrol in breast cancer treatment
6. Sulforaphane in breast cancer treatment
7. Epigallocatechin-3-gallate in breast cancer treatment
8. Allicin in breast cancer treatment
9. Berberine in breast cancer treatment
10. Vinca alkaloids in breast cancer treatment

Über Autor(innen)

Mishra, Yachana
Dr. Yachana Mishra, PhD, is an Associate Professor at the School of Bioengineering and Biosciences, Lovely Professional University, Phagwara (Punjab), India. She received her Ph.D. degree from Indian Grassland and Fodder Research Institute (IGFRI), Bundelkhand University, Jhansi (U.P.), India. Dr. Mishra has published more than 55 research and review articles in journals of high repute, 25 book chapters, 7 books, 4 Indian patents (Filed) and 5 Indian Copyrights (Granted). She has 15+ years of academic and research experience. She is a life member of different reputed organizations like Indian Science Congress Association, Kolkata (India), and the Society of Pharmaceutical Education and Research (SPER), India. She also serves as a reviewer of various journals of high repute. Her research areas include nanomedicine, cancer, diabetes, phytopharmaceuticals, and nanocarriers.

Mishra, Vijay
Dr. Vijay Mishra, PhD, is a Professor at the School of Pharmaceutical Sciences, Lovely Professional University, Phagwara (Punjab), India. He earned his doctoral degree in Pharmaceutical Sciences from Dr. H.S. Gour Central University, Sagar (MP), India. He has 15+ years of academic and research experience. Dr. Mishra has authored more than 160 research and review articles in various peer-reviewed international journals of high repute, 25 book chapters, 9 books, 10 Indian patents (filed and published), 1 Australian and 1 Indian patent (granted) and 5 Indian Copyrights (Granted). He has an h-index 43 and 6400+ citations to his credit. He has been a recipient of several internationally acclaimed fellowships and awards including Graduate Research Fellowship (AICTE, New Delhi), UGC-BSR Senior Research Fellowship (UGC, New Delhi) and International Travel Award/Grant (DBT, New Delhi). He is a life member of Indian Science Congress Association, Kolkata, India. He serves as an Editorial Board Member of various peer-reviewed journals. Dr. Mishra has been selected as the World's Top 2% scientists in 2021, 2022, 2023, and 2024 as per Stanford University, USA report. His current research interests encompass nanomedicine, cancer, phytotherapeutics, dendrimers, carbon nanotubes, and novel drug delivery systems.